Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-08-28

Clinical Trial Update: A Study of TRS01 in Subjects With Active Non-infectious Anterior Uveitis Including Subjects With Uveitic Glaucoma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of TRS01 in subjects with active non-infectious anterior uveitis, including uveitic glaucoma, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRS01

Snippet

Sponsor: Tarsier Pharma | Conditions: Non-infectious Anterior Uveitis, Uveitic Glaucoma | Phase 3 | Status: COMPLETED